Wednesday, Jun 7, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Business | Safety Highest Priority While Developing Adult Covid Vaccination Dr Krishna Ella

Safety highest priority while developing adult Covid vaccination: Dr Krishna Ella

Hyderabad: When Bharat Biotech was looking at developing vaccines after the Covid outbreak, the highest priority was ensuring the safety in adult vaccination, Dr Krishna Ella, managing director, Bharat Biotech International noted on Thursday. Speaking at a panel session on the first day of BioAsia titled ‘Two years into the pandemic – Challenges, successes and […]

By Telangana Today
Published Date - 07:18 PM, Thu - 24 February 22
Safety highest priority while developing adult Covid vaccination: Dr Krishna Ella
whatsapp facebook twitter telegram

Hyderabad: When Bharat Biotech was looking at developing vaccines after the Covid outbreak, the highest priority was ensuring the safety in adult vaccination, Dr Krishna Ella, managing director, Bharat Biotech International noted on Thursday.

Speaking at a panel session on the first day of BioAsia titled ‘Two years into the pandemic – Challenges, successes and what next?’, Dr Ella said, “I looked at only one thing – safety in adult vaccination. I looked at our expertise in viral vaccination. And we are extremely good in viral and inactivated vaccines as well as vero cell culture. And we have seven vaccines in inactivated vaccines category. We are one of the very few people in the world who have expertise in inactivated vaccine strategy domain. And the vero cell culture – we are Number 1 with 13 vaccines platform. We wanted to pool in what we are good at.”

“We took help of ViroVax in US for adjuvants, and we scaled up with IICT in Hyderabad. We also needed public private partnership because as private companies we cannot do studies on monkeys in India. National Institute of Virology in Pune has got that expertise. We used the facility to prove that it works on animals,” he added.

Efficacy trial was important. Also, the regulatory was a bit delayed in the beginning in India. If that was a little activated, the mRNA vaccine could shift before the animal trial, and the company could shift straight to human trial. Bharat Biotech was the only company doing an efficacy trial during a delta epidemic.

Dr Ella further informed, “We have done a detailed analysis on nasal vaccines. In the next one week, we are releasing a public statement on tuberculosis such as a partnership on a phase 3 trial. Tuberculosis elimination is on the Prime Minister’s agenda for 2025.”


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • Bharat Biotech
  • BioAsia
  • COVID
  • Dr Krishna Ella

Related News

  • Opinion: Pursue own foreign policy

    Opinion: Pursue own foreign policy

  • Editorial: Indo-US ties on upswing

    Editorial: Indo-US ties on upswing

  • Two children injured in wall collapse in Hyderabad

    Two children injured in wall collapse in Hyderabad

  • WTC Final: Head onslaught rattles India, Australia reaches 327/3 on Day 1

    WTC Final: Head onslaught rattles India, Australia reaches 327/3 on Day 1

  • Recykal: Helping waste recyclers using technology

    Recykal: Helping waste recyclers using technology

  • Hyderabad: Murgi Chowk to regain its lost glory

    Hyderabad: Murgi Chowk to regain its lost glory

Latest News

  • Health and Tech: Carbon material vital in medical tech, devices

    4 hours ago
  • Fight Centre’s lopsided policies: KCR

    3 hours ago
  • Cartoon: June 8, 2023

    4 hours ago
  • Straight bat: Franchise cricket is here to dominate

    4 hours ago
  • Telangana: CEO assures political parties to resolve all issues related to electoral rolls

    4 hours ago
  • All tanks filled with water in Telangana: Koppula

    4 hours ago
  • Telangana: Action demanded against man for attempting to rape tribal woman in Asifabad

    5 hours ago
  • Species traits, geography predict genetic diversity in centipedes: Study

    5 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam